The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Radioimmunotherapy with alpha-emitting nuclides
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MIRD primer for absorbed dose calculations
LOEVINGER, R., Budinger, T. F., & Watson, E. E. (1988) · Medical Entomology and Zoology · Cited by 552
Sgouros, G., Ballangrud, Å., Jurcic, J. G., McDevitt, M. R., Humm, J. L., Erdi, Y. E., Mehta, B. M., Finn, R. D., Larson, S. M., & Scheinberg, D. A. (1999) · PubMed · Cited by 207
Self-citationKozak, R. W., Atcher, R. W., Gansow, O. A., Friedman, A. M., Hines, J. J., & Waldmann, T. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.2.474 · Cited by 197
Goddu, S. M., Howell, R. W., & Rao, D. V. (1994) · PubMed · Cited by 174
Radiobiology of α Particles: III. Cell Inactivation by α-Particle Traversals of the Cell Nucleus
Raju, M. R., Eisen, Y., Carpenter, S., & Inkret, W. C. (1991) · Radiation Research · doi:10.2307/3578139 · Cited by 167
Zalutsky, M. R., Garg, P. K., Friedman, H. S., & Bigner, D. D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.18.7149 · Cited by 156
Radioimmunotherapy with Alpha-Particle-Emitting Immunoconjugates
Macklis, R. M., Kinsey, B. M., Kassis, A. I., Ferrara, J. L. M., Atcher, R. W., Hines, J. J., Jr., Coleman, C. N., Adelstein, S. J., & Burakoff, S. J. (1988) · Science · doi:10.1126/science.2897133 · Cited by 155
MIRD : radionuclide data and decay schemes
Weber, D. A., & Dillman, L. T. (1989) · Society of Nuclear Medicine eBooks · Cited by 141
Biological and immunological features of humanized M195 (anti-CD33) monoclonal antibodies.
Caron, P. C., Co, M. S., Bull, M. K., et al. (1992) · PubMed · Cited by 135
Improved in vivo stability and tumor targeting of bismuth-labeled antibody.
Ruegg, C. L., Anderson-Berg, W. T., Brechbiel, M. W., Mirzadeh, S., Gansow, O. A., & Strand, M. (1990) · PubMed · Cited by 130
Cited by
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
Parker, C., Nilsson, S., Heinrich, D., Helle, S. I., O'Sullivan, J. M., Fosså, S. D., Chodacki, A., Wiechno, P., Logue, J., Seke, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213755 · Cited by 3,408
Monoclonal antibody therapy of cancer
Adams, G. P., & Weiner, L. M. (2005) · Nature Biotechnology · doi:10.1038/nbt1137 · Cited by 1,246
Radiopharmaceutical therapy in cancer: clinical advances and challenges
Sgouros, G., Bodei, L., McDevitt, M. R., & Nedrow, J. R. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0073-9 · Cited by 963
Self-citationImproving the efficacy of antibody-based cancer therapies
Carter, P. (2001) · Nature Reviews Cancer · doi:10.1038/35101072 · Cited by 833
Sgouros, G., Roeske, J. C., McDevitt, M. R., Palm, S., Allen, B. J., Fisher, D. R., Brill, A. B., Song, H., Howell, R. W., & Akabani, G. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.058651 · Cited by 552
Self-citationTumor therapy with targeted atomic nanogenerators.
McDevitt, M. R., Ma, D., Lai, L. T., Simon, J., Borchardt, P., Frank, R. K., Wu, K., Pellegrini, V., Curcio, M. J., Miederer, M., et al. (2001) · Science · doi:10.1126/science.1064126 · Cited by 501
Self-citationTargeted α particle immunotherapy for myeloid leukemia
Jurcic, J. G., Larson, S. M., Sgouros, G., McDevitt, M. R., Finn, R. D., Divgi, C. R., Ballangrud, Å. M., Hamacher, K. A., Ma, D., Humm, J. L., et al. (2002) · Blood · doi:10.1182/blood.v100.4.1233.h81602001233_1233_1239 · Cited by 472
Self-citationAntibody-targeted radiation cancer therapy
Milenic, D. E., Brady, E. D., & Brechbiel, M. W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1413 · Cited by 380
The role of coordination chemistry in the development of target-specific radiopharmaceuticals
Liu, S. (2004) · Chemical Society Reviews · doi:10.1039/b309961j · Cited by 351
An overview of targeted alpha therapy
Kim, Y.-S., & Brechbiel, M. W. (2012) · Tumor Biology · doi:10.1007/s13277-011-0286-y · Cited by 278
Rosenblat, T. L., McDevitt, M. R., Mulford, D. A., Pandit-Taskar, N., Divgi, C. R., Panageas, K. S., Heaney, M. L., Chanel, S., Morgenstern, A., Sgouros, G., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0382 · Cited by 271
Self-citationDesign and synthesis of 225Ac radioimmunopharmaceuticals.
McDevitt, M. R., Ma, D., Simon, J., Frank, R. K., & Scheinberg, D. A. (2002) · Applied Radiation and Isotopes · doi:10.1016/s0969-8043(02)00167-7 · Cited by 225
Self-citationMiederer, M., Scheinberg, D. A., & McDevitt, M. R. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.04.009 · Cited by 210
Self-citationDevelopment of 225Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences
Robertson, A. K. H., Ramogida, C. F., Schaffer, P., & Radchenko, V. (2018) · Current Radiopharmaceuticals · doi:10.2174/1874471011666180416161908 · Cited by 202
Apostolidis, C., Molinet, R., McGinley, J., Abbas, K., Möllenbeck, J., & Morgenstern, A. (2005) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2004.06.013 · Cited by 176
Production of actinium-225 for alpha particle mediated radioimmunotherapy.
Boll, R. A., Malkemus, D., & Mirzadeh, S. (2005) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2004.12.003 · Cited by 171
Miederer, M., Henriksen, G., Alke, A., Mossbrugger, I., Quintanilla-Martinez, L., Senekowitsch-Schmidtke, R., & Essler, M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4647 · Cited by 155
Targeted α-therapy–past, present, future?
Brechbiel, M. W. (2007) · Dalton Transactions · doi:10.1039/b704726f · Cited by 151
Graf, F., Fahrer, J., Maus, S., Morgenstern, A., Bruchertseifer, F., Venkatachalam, S., Fottner, C., Weber, M. M., Huelsenbeck, J., Schreckenberger, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088239 · Cited by 143
“characterized by a high energy and high linear energy transfer (LET) causing high cellular cytotoxicity at the site of radionuclide decay [3].”
BackgroundA bone marrow toxicity model for 223 Ra alpha-emitter radiopharmaceutical therapy
Hobbs, R. F., Song, H., Watchman, C. J., Bolch, W. E., Aksnes, A.-K., Ramdahl, T., Flux, G. D., & Sgouros, G. (2012) · Physics in Medicine and Biology · doi:10.1088/0031-9155/57/10/3207 · Cited by 122
Self-citationA nephron-based model of the kidneys for macro-to-micro α-particle dosimetry
Hobbs, R. F., Song, H., Huso, D. L., H Sundel, M., & Sgouros, G. (2012) · Physics in Medicine and Biology · doi:10.1088/0031-9155/57/13/4403 · Cited by 61
“In such scenarios, the MIRD committee (24), along with others (2, 25) have recommended cell-level and microdosimetry calculations that are based on a priori bio-distribution information obtained from pre-clinical or, when the sub-cellular distribution is also relevant, cell-based studies.”
BackgroundMethodSelf-citation
Metadata
- Authors
- McDevitt, M. R., Sgouros, G., Finn, R. D., Humm, J. L., Jurcic, J. G., Larson, S. M., & Scheinberg, D. A.
- Venue
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 1998-09-01
- Volume
- 25
- Issue
- 9
- Pages
- 1341-1351
- ISSN
- 1619-7070 (ISSN-L)
- 1619-7089
- OpenAlex
- W2080585386
- Cited by
- 403
- References
- 33
- FWCI
- 15.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.